Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin burning sensation, Sleep disorder
Clinical narrative: Severe headache; low grade fever; severe nausea; severe nausea and abdominal pain; severe to moderate body aches; severe to moderate body aches and bone achiness; extreme fatigue; soreness at injection site; mild dizziness; feeling as if I were to have a recurrence of Shingles; severe to moderate flushing; redness on face, neck, and trunk with feeling hot all over; redness on face, neck, and trunk with feeling hot all over; increased aurora migraines; SaO2 levels which dropped from  my usual 98-99% to 92-94% with slight elevation in HR; SaO2 levels which dropped from my usual 98-99% to 92-94% with slight elevation in HR; This is a spontaneous report from a contactable health care professional (other HCP; patient herself). A 47-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EL3302; Expiration date was not reported), via unspecified route of administration in the right arm on 20Jan2021 14:15 (at the age of 47-years-old) at a single dose for covid-19 immunization at a nursing home/ Senior Living Facility. Medical history included early menopause on HRT at this time, aurora migraines with or without headache (migraine with aura), chronic anxiety and depression; all of which from an unknown date and unknown if ongoing. Medical history also included allergies with milk and color dyes. Concomitant medications included medroxyprogesterone, clonazepam, quetiapine, and estradiol (ESTRA); all were taken for an unspecified indication and start and stop dates were not reported. The patient previously took Cefalexin monohydrate (KEFLEX) and experienced drug allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 21Jan2021, the patient experienced severe headache, low grade fever, severe nausea and abdominal pain, severe to moderate body aches and bone achiness, extreme fatigue, soreness at injection site, mild dizziness, feeling as if she were to have a recurrence of Shingles, severe to moderate flushing and redness on face, neck, and trunk with feeling hot all over, increased aurora migraines (flushing, headache and mild fatigue were reported to be within 24 hours and onset of severe symptoms were reported to have begun the following day approximately 20 hours post second injection). The patient's oxygen saturation levels also dropped from her usual 98-99% to 92-94% and had slight elevation in heart rate on 21Jan2021. The patient's blood pressure was not checked. All severe to moderate symptoms were reported to have lasted for seven days post vaccination until 26Jan2021 and events fatigue and headache lasted for next two weeks. The patient was reported to have start feeling better around 02Feb2021. There were no issues with any other vaccines in her life. The patient never had mRNA vaccine before these two (first dose was reported to be uneventful). The events were reported as non-serious. No treatment or medical intervention was received for the events. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal swab): inconclusive on 06Jan2021 and negative on 08Jan2021; and oxygen saturation: 92-94% on 21Jan2021. The outcome of the events severe nausea and abdominal pain, severe to moderate body aches and bone achiness and severe to moderate flushing and redness on face, neck, and trunk with feeling hot all over was recovered on 26Jan2021 (with the reported duration of 7 days); outcome of events: extreme fatigue and severe headache was also recovered on an unspecified date (which was reported to have lasted for the next 2 weeks); and outcome of events low grade fever, soreness at injection site, mild dizziness, feeling as if I were to have a recurrence of Shingles, increased aurora migraines and SaO2 levels which dropped from my usual 98-99% to 92-94% was recovering.  No follow-up attempts are possible. No further information is expected.